Pharmaceutical companies extend their AI-intelligence to create more effective trials.

Posted by on Feb 9, 2023 in Blog, Patient Services, Pharma, pharma business | 0 comments

New (DNA-based) ways of drugs discovery render more (potential) medications for ever more personalized medicines – It impacts their organizational and marketing substantially.

How is the pharmaceutical industry going to support patients effectively, when numbers of targeted patients appear to fall because of (the need of) individualization by personalized medicine?

Read More

Integration should be the trend of health care development 2014

Posted by on Feb 19, 2014 in Blog, Care for Health, eHealth, Experience Co-Creation in Care - Ec3, health business | 0 comments

As cost and outcomes of care are duly becoming the main reference points for quality of care, it is important that immanent fragmentation or even chaos in care paths is prevented. Integration should therefore be the relevant trend in health care development 2014. Here we explain three increasing modi of integration in care: co-operation, co-creation and experience co-creation.

Read More

Health Care Trends 2014

Posted by on Feb 18, 2014 in Blog, eHealth, health business, Pharma | 0 comments

Health care trend of trends 2014?
What have been named as trends in health care development for 2014?
Reviewing several blogs, these I came to mention:
1. Financial concerns;
2. Patient empowerment;
3. Connected health, eHealth;
4. Redefining the health industry and
5. Data security.
Is that what it is? No, we should look at what “the” trend in health care development should be. See for that part 2.

Read More

Onward to Telecardiology?

Posted by on Aug 21, 2009 in Blog, Care for Health, eHealth, health business | 0 comments

Recently, I focused on the developments in the technology of implantable pacemakers and defibrillators (http://bit.ly/8VRkZP [1]) . I did so in the course of a consult to one of the affiliates of the cardiac devices industry in the Netherlands. I was asked to think along in the further development of cardiological care around these devices. The intention was to develop what was called as remote monitoring of cardiac devices into a design of an adequate model for integrated care in cardiology.
In reflection on the information I gathered, I distinguished two realms of development, each with their own dimensions. To implement the technological features to the conduct of care and benefit from its outcomes and processes, and specifically for the benefits of the patient, both realms of developments need to be actively attended to…
Originally posted on “Value innovation in medical and life sciences”; August 21th, 2009

Read More